ALGN
Align Technology Inc. (ALGN) is a notable player in the healthcare industry, particularly known for its innovative dental products. With a market capitalization of $15.75 billion, Align stands as a significant entity in its sector. The company's Price-to-Earnings (P/E) ratio of 36.04 suggests a relatively high investor expectation for future earnings growth, although its recent earnings growth rate has been negative at -1.9%. This indicates potential challenges in maintaining its profitability amidst market fluctuations.
The company's Return on Equity (ROE) of 11.401% reveals that Align generates moderate returns on shareholders' equity, which could be attractive to those seeking steady, albeit not exceptionally high, returns. The debt-to-equity ratio of 2.445 shows Align's conservative leverage, implying that the company uses more equity than debt to finance its operations, reducing financial risk.
With a current ratio of 1.259, Align demonstrates a comfortable ability to meet its short-term liabilities, reflecting a stable liquidity position. The operating margin of 16.604% and EBITDA margin of 20.749% provide insight into the company's capability to maintain profitability in its operational activities. However, with modest revenue growth of 1.8%, Align's expansion pace may appear limited to potential investors.
The trailing PEG ratio of 1.2439 suggests that the stock may be trading at a fair value considering its projected earnings growth, providing a balanced perspective to growth-oriented investors. Align's free cash flow of $394.52 million supports its operational flexibility and ability to fund strategic projects or repay debt.
Institutional investors hold a dominant 90.255% of the company's shares, indicating strong external confidence in Align's long-term potential and stability. This high level of institutional ownership could also lead to stock price volatility if large positions are adjusted.
Last Updated: January 14, 2025
| Metric | Value |
|---|---|
| Market Cap | 16.11 B |
| P/E Ratio | 36.76 |
| ROE | 11.40 % |
| Debt to Equity | 3.235 |
| Operating Margin | 16.60 % |
| Free Cash Flow | 413.27 M |
| Institutional Holdings | 89.88 % |
| Revenue Growth | 1.80 % |
Dive into Align Technology's Competitive Terrain
- Clear Aligners: At the core of Align Technology’s portfolio are clear aligners, with Invisalign leading the charge. This segment is contested by top-tier and emerging players pushing innovation boundaries.
- Dental Imaging Systems: Beyond aligners, Align Technology extends its influence in dental imaging, broadening practitioners' capabilities and enhancing patient experiences.
- Digital Dentistry Platforms: Align Technology’s digital platforms offer seamless workflows and customer engagement, but the competition seeks to disrupt its integrated digital ecosystem.
Align Technology’s leadership within the orthodontic industry thrives on its pioneering spirit and commitment to quality. The constant evolution of dental technologies spells both opportunities and challenges; yet, Align’s recognition and adaptability remain formidable strengths. For investors keen on the dental sector’s bright future, Align offers a vantage point teeming with potential, provided it continuously refines its competitive strategies and technological prowess.
Disclaimer: The information provided here is for educational and informational purposes only. While we strive to ensure the accuracy and reliability of the data, we do not make any guarantees regarding its completeness or accuracy. The analysis and metrics provided should not be considered as investment advice, and any actions taken based on this information are at your own risk. We do not assume responsibility for any financial losses or other damages incurred from the use of this data. Please consult with a qualified financial advisor before making any investment decisions.